A Pitfall of the Androgen Deprivation Therapy for Salivary Duct Carcinoma: Hormonal Therapy-Induced Castrate-Resistant Prostate Cancer

被引：0
|
作者：
Shugo Yajima
Yasukazu Nakanishi
Shunya Matsumoto
Kenji Tanabe
Hitoshi Masuda
机构：
[1] National Cancer Center Hospital East,
来源：
Journal of Maxillofacial and Oral Surgery | 2022年 / 21卷
关键词：
Androgen deprivation therapy; Androgen receptors; Castration-resistant prostate cancer; Combined androgen blockade; Prostate-specific antigen; Salivary duct carcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1097 / 1100
页数：3
相关论文
共 50 条
  • [31] Complications of androgen deprivation therapy in men with prostate cancer
    Chen A.C.
    Petrylak D.P.
    Current Oncology Reports, 2004, 6 (3) : 209 - 215
  • [32] Intermittent Androgen Deprivation Therapy in Advanced Prostate Cancer
    Ajjai Alva
    Maha Hussain
    Current Treatment Options in Oncology, 2014, 15 : 127 - 136
  • [33] Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question
    Caramella, Irene
    Dalla Volta, Alberto
    Bergamini, Marco
    Cosentini, Deborah
    Valcamonico, Francesca
    Berruti, Alfredo
    ENDOCRINE, 2022, 78 (03) : 441 - 445
  • [34] Cardiovascular Effects of Androgen Deprivation Therapy in Prostate Cancer
    Megha Agarwal
    Timothy Canan
    Greg Glover
    Nidhi Thareja
    Andre Akhondi
    Joshua Rosenberg
    Current Oncology Reports, 2019, 21
  • [35] Cardiovascular Risks of Androgen Deprivation Therapy for Prostate Cancer
    Corona, Giovanni
    Filippi, Sandra
    Bianchi, Nicola
    Dicuio, Mauro
    Rastrelli, Giulia
    Concetti, Sergio
    Sforza, Alessandra
    Maggi, Mario
    WORLD JOURNAL OF MENS HEALTH, 2021, 39 (03) : 429 - 443
  • [36] Maintenance of androgen deprivation therapy or testosterone supplementation in the management of castration-resistant prostate cancer: that is the question
    Irene Caramella
    Alberto Dalla Volta
    Marco Bergamini
    Deborah Cosentini
    Francesca Valcamonico
    Alfredo Berruti
    Endocrine, 2022, 78 : 441 - 445
  • [37] Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
    Nicoletta Ferrari
    Ilaria Granata
    Matteo Capaia
    Marina Piccirillo
    Mario Rosario Guarracino
    Roberta Venè
    Antonella Brizzolara
    Andrea Petretto
    Elvira Inglese
    Martina Morini
    Simonetta Astigiano
    Adriana Agnese Amaro
    Francesco Boccardo
    Cecilia Balbi
    Paola Barboro
    Cell Communication and Signaling, 15
  • [38] Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
    Ferrari, Nicoletta
    Granata, Ilaria
    Capaia, Matteo
    Piccirillo, Marina
    Guarracino, Mario Rosario
    Vene, Roberta
    Brizzolara, Antonella
    Petretto, Andrea
    Inglese, Elvira
    Morini, Martina
    Astigiano, Simonetta
    Amaro, Adriana Agnese
    Boccardo, Francesco
    Balbi, Cecilia
    Barboro, Paola
    CELL COMMUNICATION AND SIGNALING, 2017, 15 : 51
  • [39] Single Infusion of Zoledronic Acid to Prevent Androgen Deprivation Therapy-induced Bone Loss in Men With Hormone-naive Prostate Carcinoma
    Satoh, Takefumi
    Kimura, Masaki
    Matsumoto, Kazumasa
    Tabata, Ken-ichi
    Okusa, Hiroshi
    Bessho, Hicleharu
    Iwamura, Masatsugu
    Ishiyama, Hiromichi
    Hayakawa, Kazushige
    Baba, Shiro
    CANCER, 2009, 115 (15) : 3468 - 3474
  • [40] Discovery of prostate specific antigen pattern to predict castration resistant prostate cancer of androgen deprivation therapy
    Kim, Yejin
    Park, Yong Hyun
    Lee, Ji Youl
    Choi, In Young
    Yu, Hwanjo
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2016, 16
12345